标题
Vaccines against Meningococcal Diseases
作者
关键词
-
出版物
Microorganisms
Volume 8, Issue 10, Pages 1521
出版商
MDPI AG
发表日期
2020-10-03
DOI
10.3390/microorganisms8101521
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience
- (2020) Catherine Isitt et al. ARCHIVES OF DISEASE IN CHILDHOOD
- First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia
- (2020) Helen S Marshall et al. MEDICAL JOURNAL OF AUSTRALIA
- Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
- (2020) Shamez N. Ladhani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
- (2020) Helen S. Marshall et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States
- (2020) Lee-Jah Chang et al. VACCINE
- Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
- (2020) Germán Áñez et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
- (2020) Timo Vesikari et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study
- (2020) Judith Kirstein et al. Human Vaccines & Immunotherapeutics
- GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
- (2020) Francesca Micoli et al. Vaccines
- Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
- (2019) Helen Findlow et al. Eurosurveillance
- Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)
- (2019) Corwin A. Robertson et al. VACCINE
- Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
- (2019) Alessandro Muzzi et al. VACCINE
- Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents
- (2019) Timo Vesikari et al. VACCINE
- Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine
- (2019) Terry Nolan et al. VACCINE
- Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials
- (2019) Michael White et al. LANCET INFECTIOUS DISEASES
- Long-term effectiveness of MenAfriVac
- (2019) Judith E Mueller LANCET INFECTIOUS DISEASES
- Introduction of a second MenB vaccine into Europe – needs and opportunities for public health
- (2019) Jamie Findlow et al. Expert Review of Vaccines
- Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis
- (2019) Bing Wang et al. VACCINE
- Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review
- (2019) Femke van Kessel et al. Journal of Global Health
- Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch
- (2019) G. Deceuninck et al. VACCINE
- Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults
- (2019) Federico Martinón-Torres et al. Human Vaccines & Immunotherapeutics
- Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines
- (2019) Helen Petousis-Harris et al. Frontiers in Immunology
- The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
- (2019) Vega Masignani et al. Frontiers in Immunology
- MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults
- (2019) Mary Tipton et al. VACCINE
- Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces
- (2019) Jae Hyoung Im et al. VACCINE
- From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine
- (2018) John L. Perez et al. Expert Review of Vaccines
- Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines
- (2018) Leszek Szenborn et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults
- (2018) Johannes Beeslaar et al. VACCINE
- Vaccination strategies for the prevention of meningococcal disease
- (2018) Scott Vuocolo et al. Human Vaccines & Immunotherapeutics
- Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults
- (2018) Xavier Sáez-Llorens et al. Human Vaccines & Immunotherapeutics
- Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development
- (2018) A. W. Dretler et al. Human Vaccines & Immunotherapeutics
- An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine
- (2018) Pavitra Keshavan et al. Expert Review of Vaccines
- Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents
- (2018) Lidia C. Serra et al. JOURNAL OF ADOLESCENT HEALTH
- Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study
- (2018) Wilbur H Chen et al. LANCET INFECTIOUS DISEASES
- Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study
- (2018) Jo Anne Welsch et al. VACCINE
- The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations
- (2018) Reinaldo Acevedo et al. Expert Review of Vaccines
- NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies
- (2018) Alessia Liguori et al. mBio
- Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies
- (2018) Robert Booy et al. Human Vaccines & Immunotherapeutics
- Emerging experience with meningococcal serogroup B protein vaccines
- (2017) Daniela Toneatto et al. Expert Review of Vaccines
- Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative
- (2017) Ray Borrow et al. JOURNAL OF INFECTION
- Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006–2015
- (2017) I. Parent du Chatelet et al. JOURNAL OF INFECTION
- Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
- (2017) Helen Petousis-Harris et al. LANCET
- Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data
- (2017) Caroline L Trotter et al. LANCET INFECTIOUS DISEASES
- Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: Lessons of the Normandy campaign
- (2017) Julien Sevestre et al. VACCINE
- Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme
- (2016) G. L. LAWRENCE et al. EPIDEMIOLOGY AND INFECTION
- Routinely vaccinating adolescents against meningococcus: targeting transmission & disease
- (2016) Volker Vetter et al. Expert Review of Vaccines
- The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
- (2016) Ray Borrow et al. Expert Review of Vaccines
- Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements
- (2016) Federico Martinón-Torres JOURNAL OF ADOLESCENT HEALTH
- The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines
- (2016) Stephen I. Pelton JOURNAL OF ADOLESCENT HEALTH
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
- (2016) Sydel R Parikh et al. LANCET
- Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
- (2016) Nicole E. Basta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
- (2016) Massimiliano Biagini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine
- (2016) Corwin A. Robertson et al. VACCINE
- Global epidemiology of capsular group W meningococcal disease (1970–2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex
- (2016) Mustapha M. Mustapha et al. VACCINE
- Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular polysaccharide-based vaccine
- (2016) Rikhav P. Gala et al. VACCINE
- Household transmission of Neisseria meningitidis in the African meningitis belt: a longitudinal cohort study
- (2016) Oumer Ali et al. Lancet Global Health
- Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015
- (2015) H Campbell et al. Eurosurveillance
- Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives
- (2015) Jane Whelan et al. Expert Review of Vaccines
- The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
- (2015) JOURNAL OF INFECTIOUS DISEASES
- Persistence of Meningococcal Antibodies and Response to a Third Dose After a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
- (2015) Xavier Saez-Llorens et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Comparative Assessment of a Single Dose and a 2-Dose Vaccination Series of a Quadrivalent Meningococcal CRM-Conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age
- (2015) William Johnston et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination
- (2015) Stan L. Block et al. VACCINE
- A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
- (2015) Stan L. Block et al. VACCINE
- Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents
- (2015) Xavier Saez-Llorens et al. Human Vaccines & Immunotherapeutics
- Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
- (2015) Jessica R. MacNeil et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Impact of the Meningococcal Serogroup C Conjugate Vaccine in Canada Between 2002 and 2012
- (2014) M. Sadarangani et al. CLINICAL INFECTIOUS DISEASES
- A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination
- (2014) Merijn W. Bijlsma et al. CLINICAL INFECTIOUS DISEASES
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- (2014) Robert C Read et al. LANCET
- Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
- (2013) DM Daugla et al. LANCET
- Effectiveness of meningococcal serogroup C vaccine programmes
- (2013) Ray Borrow et al. VACCINE
- Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
- (2013) Johan Holst et al. Human Vaccines & Immunotherapeutics
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
- (2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant CLINICAL INFECTIOUS DISEASES
- Meningococcal disease: Clinical presentation and sequelae
- (2012) David Pace et al. VACCINE
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- (2012) Eva Hong et al. VACCINE
- Structure of the uncomplexedNeisseria meningitidisfactor H-binding protein fHbp (rLP2086)
- (2011) Laura Cendron et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- Structure of the C-terminal Domain ofNeisseriaHeparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine againstNeisseria meningitidis
- (2011) Veronica Esposito et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak
- (2011) François Caron et al. LANCET INFECTIOUS DISEASES
- Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine
- (2011) Jessica R. MacNeil et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Effectiveness of Serogroup C Meningococcal Conjugate Vaccine
- (2011) Philippe De Wals et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age
- (2010) Scott A. Halperin et al. VACCINE
- Meningococcal C conjugate vaccine: The experience in England and Wales
- (2009) Helen Campbell et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started